Factory of the Future Terumo Europe has been recognized as a Factory of the Future for 2026-2028, signaling advanced manufacturing capabilities, modernization potential, and opportunities to offer complementary process optimization, automation, and equipment upgrades to sustain their improved production standards.

Monitoring System Launch The introduction of the CDI OneView Monitoring System with MDR certification presents a potential cross-sell opportunity for advanced monitoring, data analytics, and remote management solutions to optimize cardiovascular surgery technologies and enhance post-market service offerings.

Diverse Product Portfolio Terumo Europe operates across five business units including Interventional Systems, Hospital Care Solutions, Cardiovascular and Life Care Solutions, which creates multiple entry points for upsell and bundles with hospital procurement teams seeking integrated device solutions and service packages.

Strategic Partnerships Recent collaborations, such as with Eisai on drug-device combinations and Orchestra BioMed partnerships, indicate openness to joint development and innovative care pathways, suggesting opportunities to co-create new autoinjector or combination device solutions and expand market reach.

Clinical and Innovation Focus Active clinical studies and launching next-generation stents (Ultimaster family) reflect a strong R&D cadence and clinician engagement, offering sales opportunities in early adoption programs, training services, and value-based clinical evidence packages for hospitals adopting new devices.